Related Experiment Video
Updated: May 5, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
The challenges of obtaining ethics approval for a randomized, double-blind, placebo-controlled research study in
1Barts and the London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, EC1M 6BQ, UK.
Background And Objective:
A PhD project involving designing and implementing a small-scale clinical trial at Jersey General Hospital encountered a variety of difficulties in obtaining ethics approval due to Jersey's unique legal and constitutional position. Clarification of the necessary route of application took some 28 months. It was established that only local ethics approval is required for clinical trials taking place in the Channel Islands and that there is no need for Medicines and Healthcare products Regulatory Agency (MHRA) approval in the form of Clinical Trials Authorization (CTA), because Jersey falls outside the existing legal and regulatory framework. The experiences and findings gained from this project would prove of use to other researchers planning to conduct clinical trials in the Channel Islands.
Related Concept Videos
Ethics in Research
Blinding
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Blind Procedures
Bioequivalence studies: Biowaivers
Bioavailability Study Design: Healthy Subjects Versus Patients

